{"id":920,"date":"2021-03-03T00:13:45","date_gmt":"2021-03-03T00:13:45","guid":{"rendered":"https:\/\/mitogendx.com\/faq\/est-il-important-de-definir-les-titres-pour-hep-2-ifa\/"},"modified":"2021-03-03T00:13:50","modified_gmt":"2021-03-03T00:13:50","slug":"est-il-important-de-definir-les-titres-pour-hep-2-ifa","status":"publish","type":"faq","link":"https:\/\/mitogen.dev5.oracastdev.com\/fr\/faq\/est-il-important-de-definir-les-titres-pour-hep-2-ifa\/","title":{"rendered":"Est-il important de d\u00e9finir les titres pour HEp-2 IFA?"},"content":{"rendered":"<p><em>La pr\u00e9sence d\u2019autoanticorpdies IgG \u00e0 haut litre et leur persistance au fil du temps sont caract\u00e9ristiques de plusieurs maladies rhumatismales auto-immunes, telles que le SLE, la scl\u00e9rodermie, le syndrome de Sj\u00f6gren, la maladie mixte des tissus conjonctifs et la maladie h\u00e9patique auto-immune (PBC, h\u00e9patite auto-immune). Les autoanticorps de titer \u00e9lev\u00e9s ne devraient pas \u00eatre consid\u00e9r\u00e9s comme \u00e9piph\u00e9nomenona de l\u2019infection ou de l\u2019inflammation. Cependant, autoanticorps \u00e0 bas titers (&lt;1:80) peut \u00eatre pr\u00e9sent chez les patients atteints de diverses maladies non auto-immunes (infections virales et bact\u00e9riennes, n\u00e9oplasie, etc),chez les parents de patients atteints de maladies auto-immunes et chez des sujets apparemment en bonne sant\u00e9 MitogenDx a fix\u00e9 un arr\u00eat fixe pour la positivit\u00e9 \u00e0 un litre de 1:80 pour diminuer le pourcentage de faux positifs. Une grande \u00e9tude multicentrique a montr\u00e9 que ANA sans aucune signification clinique peut \u00eatre trouv\u00e9e dans 30% des sujets sains \u00e0 un litre de 1:40 et dans 5% \u00e0 un litre de 1: 160 (6).<\/em><\/p>\n","protected":false},"template":"","class_list":["post-920","faq","type-faq","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Est-il important de d\u00e9finir les titres pour HEp-2 IFA? - MitogenDx<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Est-il important de d\u00e9finir les titres pour HEp-2 IFA? - MitogenDx\" \/>\n<meta property=\"og:description\" content=\"La pr\u00e9sence d\u2019autoanticorpdies IgG \u00e0 haut litre et leur persistance au fil du temps sont caract\u00e9ristiques de plusieurs maladies rhumatismales auto-immunes, telles que le SLE, la scl\u00e9rodermie, le syndrome de Sj\u00f6gren, la maladie mixte des tissus conjonctifs et la maladie h\u00e9patique auto-immune (PBC, h\u00e9patite auto-immune). Les autoanticorps de titer \u00e9lev\u00e9s ne devraient pas \u00eatre consid\u00e9r\u00e9s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/\" \/>\n<meta property=\"og:site_name\" content=\"MitogenDx\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-03T00:13:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/\",\"url\":\"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/\",\"name\":\"Est-il important de d\u00e9finir les titres pour HEp-2 IFA? - MitogenDx\",\"isPartOf\":{\"@id\":\"https:\/\/mitogendx.com\/fr\/#website\"},\"datePublished\":\"2021-03-03T00:13:45+00:00\",\"dateModified\":\"2021-03-03T00:13:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/mitogendx.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Est-il important de d\u00e9finir les titres pour HEp-2 IFA?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mitogendx.com\/fr\/#website\",\"url\":\"https:\/\/mitogendx.com\/fr\/\",\"name\":\"MitogenDx\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/mitogendx.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mitogendx.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mitogendx.com\/fr\/#organization\",\"name\":\"MitogenDx\",\"url\":\"https:\/\/mitogendx.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/mitogendx.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mitogen.dev5.oracastdev.com\/wp-content\/uploads\/2020\/07\/logo.webp\",\"contentUrl\":\"https:\/\/mitogen.dev5.oracastdev.com\/wp-content\/uploads\/2020\/07\/logo.webp\",\"width\":80,\"height\":68,\"caption\":\"MitogenDx\"},\"image\":{\"@id\":\"https:\/\/mitogendx.com\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Est-il important de d\u00e9finir les titres pour HEp-2 IFA? - MitogenDx","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/","og_locale":"fr_FR","og_type":"article","og_title":"Est-il important de d\u00e9finir les titres pour HEp-2 IFA? - MitogenDx","og_description":"La pr\u00e9sence d\u2019autoanticorpdies IgG \u00e0 haut litre et leur persistance au fil du temps sont caract\u00e9ristiques de plusieurs maladies rhumatismales auto-immunes, telles que le SLE, la scl\u00e9rodermie, le syndrome de Sj\u00f6gren, la maladie mixte des tissus conjonctifs et la maladie h\u00e9patique auto-immune (PBC, h\u00e9patite auto-immune). Les autoanticorps de titer \u00e9lev\u00e9s ne devraient pas \u00eatre consid\u00e9r\u00e9s [&hellip;]","og_url":"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/","og_site_name":"MitogenDx","article_modified_time":"2021-03-03T00:13:50+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/","url":"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/","name":"Est-il important de d\u00e9finir les titres pour HEp-2 IFA? - MitogenDx","isPartOf":{"@id":"https:\/\/mitogendx.com\/fr\/#website"},"datePublished":"2021-03-03T00:13:45+00:00","dateModified":"2021-03-03T00:13:50+00:00","breadcrumb":{"@id":"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mitogendx.com\/faq\/is-it-important-to-define-titres-for-hep-2-ifa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mitogendx.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Est-il important de d\u00e9finir les titres pour HEp-2 IFA?"}]},{"@type":"WebSite","@id":"https:\/\/mitogendx.com\/fr\/#website","url":"https:\/\/mitogendx.com\/fr\/","name":"MitogenDx","description":"","publisher":{"@id":"https:\/\/mitogendx.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mitogendx.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/mitogendx.com\/fr\/#organization","name":"MitogenDx","url":"https:\/\/mitogendx.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mitogendx.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/mitogen.dev5.oracastdev.com\/wp-content\/uploads\/2020\/07\/logo.webp","contentUrl":"https:\/\/mitogen.dev5.oracastdev.com\/wp-content\/uploads\/2020\/07\/logo.webp","width":80,"height":68,"caption":"MitogenDx"},"image":{"@id":"https:\/\/mitogendx.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/mitogen.dev5.oracastdev.com\/fr\/wp-json\/wp\/v2\/faq\/920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mitogen.dev5.oracastdev.com\/fr\/wp-json\/wp\/v2\/faq"}],"about":[{"href":"https:\/\/mitogen.dev5.oracastdev.com\/fr\/wp-json\/wp\/v2\/types\/faq"}],"wp:attachment":[{"href":"https:\/\/mitogen.dev5.oracastdev.com\/fr\/wp-json\/wp\/v2\/media?parent=920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}